EE03871B1 - Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid - Google Patents

Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid

Info

Publication number
EE03871B1
EE03871B1 EEP199900551A EEP9900551A EE03871B1 EE 03871 B1 EE03871 B1 EE 03871B1 EE P199900551 A EEP199900551 A EE P199900551A EE P9900551 A EEP9900551 A EE P9900551A EE 03871 B1 EE03871 B1 EE 03871B1
Authority
EE
Estonia
Prior art keywords
cyanoguanidines
inhibitors
cell proliferation
proliferation
cell
Prior art date
Application number
EEP199900551A
Other languages
English (en)
Estonian (et)
Inventor
Rytter Ottosen Erik
Original Assignee
Leo Pharmaceutical Products Ltd. A/S (L�vens kemiske FabrikProduktionsaktieselskab)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd. A/S (L�vens kemiske FabrikProduktionsaktieselskab) filed Critical Leo Pharmaceutical Products Ltd. A/S (L�vens kemiske FabrikProduktionsaktieselskab)
Publication of EE9900551A publication Critical patent/EE9900551A/xx
Publication of EE03871B1 publication Critical patent/EE03871B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EEP199900551A 1997-05-29 1998-05-15 Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid EE03871B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711119.9A GB9711119D0 (en) 1997-05-29 1997-05-29 Novel cyanoguanidines
PCT/DK1998/000195 WO1998054143A1 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors

Publications (2)

Publication Number Publication Date
EE9900551A EE9900551A (et) 2000-06-15
EE03871B1 true EE03871B1 (et) 2002-10-15

Family

ID=10813249

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900551A EE03871B1 (et) 1997-05-29 1998-05-15 Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid

Country Status (19)

Country Link
US (1) US6121297A (xx)
EP (1) EP0984937A1 (xx)
JP (1) JP2001526693A (xx)
KR (1) KR20010013158A (xx)
CN (1) CN1314890A (xx)
AU (1) AU733093B2 (xx)
BG (1) BG103867A (xx)
BR (1) BR9809496A (xx)
CA (1) CA2291489A1 (xx)
EA (1) EA002037B1 (xx)
EE (1) EE03871B1 (xx)
GB (1) GB9711119D0 (xx)
HK (1) HK1039116A1 (xx)
HU (1) HUP0003150A3 (xx)
IS (1) IS5229A (xx)
NZ (1) NZ500702A (xx)
PL (1) PL337091A1 (xx)
SK (1) SK161199A3 (xx)
WO (1) WO1998054143A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061561A1 (en) 1999-04-09 2000-10-19 Shionogi Bioresearch Corp. Cyanoguanidine compounds
AU1494702A (en) 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs
WO2002094265A1 (en) * 2001-05-24 2002-11-28 Leo Pharma A/S A method of modulating nf-$g(k)b activity
US6642215B2 (en) * 2001-05-24 2003-11-04 Leo Pharma A/S Method of modulating NF-kB activity
US20030045515A1 (en) * 2001-05-24 2003-03-06 Lise Binderup Combination medicament for treatment of neoplastic diseases
RU2292344C2 (ru) * 2001-05-24 2007-01-27 Лео Фарма А/С Производные пиридилцианогуанидинов и фармацевтическая композиция на их основе
US7253193B2 (en) 2002-05-17 2007-08-07 Leo Pharma A/S Cyanoguanidine prodrugs
CA2594508C (en) 2004-12-22 2013-10-01 Leo Pharma A/S Cyanoguanidine compounds
US8173677B2 (en) 2007-09-26 2012-05-08 Gemin X Pharmaceuticals Canada Inc. Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor
WO2009072004A2 (en) 2007-09-26 2009-06-11 Gemin X Pharmaceuticals Canada, Inc. Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor
AU2010210248B2 (en) 2009-02-06 2012-08-16 Tianjin Hemay Bio-Tech Co., Ltd. Pharmaceutical compositions comprising pyridyl cyanoguanidine, process for preparing the same and use thereof
AR082886A1 (es) 2010-09-03 2013-01-16 Forma Therapeutics Inc Compuestos y composiciones farmaceuticas que los contienen
EP2634173A4 (en) 2010-10-26 2014-04-02 Tianjin Hemay Bio Tech Co Ltd POLYMORPH OF N- (6- (4-CHLOROPHENOXY) HEXYL-) N'-CYANO-N '' - (4-PYRIDYL-) GUANIDINE, PREPARATION THEREOF AND USE THEREOF

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
EE9900551A (et) 2000-06-15
CA2291489A1 (en) 1998-12-03
JP2001526693A (ja) 2001-12-18
KR20010013158A (ko) 2001-02-26
NZ500702A (en) 2001-07-27
HUP0003150A2 (en) 2001-03-28
EA002037B1 (ru) 2001-12-24
EA199901096A1 (ru) 2000-08-28
EP0984937A1 (en) 2000-03-15
GB9711119D0 (en) 1997-07-23
SK161199A3 (en) 2000-06-12
CN1314890A (zh) 2001-09-26
WO1998054143A1 (en) 1998-12-03
IS5229A (is) 1999-10-26
US6121297A (en) 2000-09-19
HK1039116A1 (zh) 2002-04-12
AU7638598A (en) 1998-12-30
PL337091A1 (en) 2000-07-31
BR9809496A (pt) 2000-06-20
BG103867A (en) 2001-05-31
AU733093B2 (en) 2001-05-03
HUP0003150A3 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
EE200000706A (et) Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid
DK1114051T3 (da) Inhibitorer for p38
ATE417828T1 (de) Heterocyclische inhibitoren von p38
ID22982A (id) PIRAZOL-PIRAZOL TERSUBSTITUSI SEBAGAI INHIBITOR KINASE p38
DE69716615T2 (de) Heterozyklische metalloproteaseinhibitoren
NO20002121D0 (no) Benzotiazol-protein-tyrosin-kinaseinhibitorer
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
EE200200140A (et) Pteridinoonid kui kinaasi inhibiitorid
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
DK1181269T3 (da) Celleproliferationsinhibitorer
FI972701A (fi) Menetelmä päätelaitteiden käytön rajoittamiseksi
EE04801B1 (et) Leptiin kui tuumorirakkude proliferatsiooni inhibiitor
PT927183E (pt) Inibidores espirociclicos de metaloproteases
EE9900551A (et) Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid
PL337331A1 (en) Cyanoguanidines as cell proliferation inhibitors
NO20004579L (no) Substituerte bisindolymaleimider for inhibering av celle- proliferering
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
ZA983065B (en) Inhibitors of protein farnesyltranferase
KR950703064A (ko) 세포증식의 저해물질, 그의 제조방법 및 이용방법
PL337031A1 (en) Cyanoguanidines as inhibitors of cell proliferation
AU7638498A (en) Cyanoguanidines as cell proliferation inhibitors
HK1020944A1 (en) Substituted heterocyclic benzocycloalkenes and their use as analgesically active compounds
GB9706652D0 (en) Inhibitors of FPT as anti-inflammatories
PL336896A1 (en) Cyanoamidines as inhibitors of cell proliferation
PL343872A1 (en) (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

MA4A Abandonment or withdrawal

Effective date: 20040515

MA4A Abandonment or withdrawal

Effective date: 20031015

MM4A Lapsed by not paying the annual fees

Effective date: 20030412